[Bone mineral density evaluation: a new tool for the urologist]

Area of Science:

• Bone health and osteoporosis management.
• Diagnostic imaging techniques for bone mineral density.

Context:

• Urologists manage patients at risk for osteoporosis, particularly those with prostate cancer undergoing androgen deprivation therapy.
• Current diagnostic tools for bone mineral density (BMD) include dual-energy X-ray absorptiometry (DXA), peripheral densitometry, and ultrasound.

Purpose:

• To update urologists on available bone mineral density diagnostic tests.
• To highlight the role of DXA as the current standard for osteoporosis diagnosis and monitoring.
• To discuss the potential future applications of peripheral densitometry and ultrasound in assessing bone mass.

Summary:

• Dual-energy X-ray absorptiometry (DXA) of the lumbar vertebrae and hip is the established standard for evaluating bone mass and diagnosing osteoporosis.
• Peripheral densitometry and ultrasound are emerging techniques with potential future clinical utility, though large-scale studies are needed to support their routine use.
• Awareness of osteoporosis diagnosis and management is crucial for urologists to reduce patient morbidity and mortality, especially in those on androgen deprivation therapy.

Impact:

• Enhances urologists' ability to diagnose and manage osteoporosis in at-risk patient populations.
• Facilitates informed clinical decision-making regarding bone density assessment and treatment strategies.
• Aims to decrease the significant impact of osteoporosis on patient morbidity and mortality.